Drug: Prograf (tacrolimus)

Manufacturer: Astellas

Route of Administration: Oral

Site of Care: Outpatient

Approved Indication: prophylaxis of organ rejection in adult and pediatric patients receiving allogenic liver, kidney, heart, or lung transplants, in combination with other immunosuppressants

Disease: solid organ transplant

Therapeutic Area: Solid Organ Transplant

Enrollment Form Link: strong>N/A

Phone Number: N/A

Fax Number: N/A

Product Website: prograf.com